Login / Signup

Low mortality from COVID-19 infection in patients with B-cell lymphoma after bispecific CD20xCD3 therapy.

Emil R KyvsgaardCaroline RileyMichael Roost ClausenMads HarsløfLine Dam HeftdalCarsten Utoft NiemannKirsten GrønbaekMartin HutchingsSimon Husby
Published in: British journal of haematology (2023)
Keyphrases
  • diffuse large b cell lymphoma
  • cardiovascular events
  • risk factors
  • type diabetes
  • nk cells
  • stem cells
  • coronary artery disease
  • cell therapy
  • bone marrow
  • smoking cessation